miR-425-5p as a tumor suppressor gene is low expressed in prostate cancer and can affect the sensitivity of prostate cancer to cisplatin through the action of GSK3β and Wnt/β-catenin signaling pathways [35]. The gene discussed is GSK3B; the disease is prostate carcinoma.